FDA NDC Directory · JSON-LD · Markdown

Dalbavancin

NDC 70069-830 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerSomerset Therapeutics, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA219604
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsDALBAVANCIN HYDROCHLORIDE (500 mg/25mL)
Marketing started20260727
Package count1

External sources

Source: openFDA. Public-domain (CC0).